2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus CART19 - SLE, Systemic Lupus Erythematosus (SLE) | Phase 1 / Phase 2 | Recruiting | Children's Hospital of Philadelphia | 24 | 2025-05-06 | 2026-09-24 |
| A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. APG-2575, Placebo - SLE | Phase 1 / Phase 2 | Recruiting | Ascentage Pharma Group Inc. | 40 | 2024-08-09 | 2025-12-16 |
Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1)
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Skin and Connective Tissue Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
CTL019 chimeric antigen receptor (1) · Lisaftoclax (1)
Ascentage Pharma Group Inc. (1) · Children's Hospital of Philadelphia (1)
China (1) · United States (1)
Caitlin Elgarten, MD (1) · Sheng Chen, Ph.D (1)